Showing results (21-30 of 68) with videos related to
Sort By:
Pageof 7
Current Opinion in Neurology|May 15, 2007
Patent foramen ovale, stroke, and cardiovascular disease in migraineHans-Christoph Diener, Tobias Kurth, David DodickNeurologic Clinics|April 4, 2024
Headaches Attributed to Disorders of HomeostasisAna Marissa Lagman-Bartolome, James Im, Jonathan GladstoneHeadache|April 19, 2005
Management of chronic daily headache: challenges in clinical practiceJoel R Saper, David Dodick, Jonathan P GladstoneHeadache|November 3, 2006
DHE in the pharmacotherapy of migraine: potential for a larger roleJoel R Saper, Stephen Silberstein, David Dodick, et al.CNS Drugs|February 9, 2005
Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled studyDavid Dodick, Jan Brandes, Arthur Elkind, et al.Cephalalgia : an International Journal of Headache|March 30, 2011
Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studiesIan D Meng, David Dodick, Michael H Ossipov, et al.Headache|May 15, 2002
How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trialsCarl G H Dahlöf, David Dodick, Andrew J Dowson, et al.Headache|March 16, 2007
Antiepileptic drugs for the treatment of chronic and episodic cluster headache: a reviewJulio Pascual, Miguel J A Láinez, David Dodick, et al.Journal of the Neurological Sciences|May 15, 2025
The World Federation of Neurology: Brain health for all ages 2025Wolfgang Grisold, David Dodick, Alla Guekht, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 10, 2010
Botulinum toxin type A and acute drug costs in migraine with triptan overuseSuzanne N Christie, Rose Giammarco, Marek Gawel, et al.Pageof 7